Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10033963 | 0.84 | MAPT (0.36) | MAPTALDH1A1SMN1; SMN2MAPK1L3MBTL1 | |
| SCHEMBL10033970 | 0.82 | ALDH1A1 (0.39) | MAPTALDH1A1SMN1; SMN2MAPK1L3MBTL1 | |
| SCHEMBL10033969 | 0.82 | ALDH1A1 (0.39) | MAPTALDH1A1SMN1; SMN2MAPK1L3MBTL1 | |
| SCHEMBL13141810 | 0.76 | MAPT (0.35) | MAPTALDH1A1SMN1; SMN2NPSR1MAPK1 | |
| SCHEMBL13142215 | 0.75 | — | — | |
| SCHEMBL11660165 | 0.68 | EPHX2 (0.40) | MAPTALDH1A1SMN1; SMN2HSD11B1 | |
| SCHEMBL11658671 | 0.66 | ERAP1 (0.46) | MAPTALDH1A1TP53SMN1; SMN2MAPK1 | |
| SCHEMBL11807403 | 0.66 | KDM4E (0.46) | MAPTALDH1A1SMN1; SMN2NPSR1MAPK1 | |
| SCHEMBL3282366 | 0.65 | LMNA (0.57) | MAPTALDH1A1TP53SMN1; SMN2NPSR1 | |
| SCHEMBL3282369 | 0.65 | LMNA (0.57) | MAPTALDH1A1TP53SMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8940806-B2 | Polymerizable compositions | BASF SE (DE) | 2015-01-27 | — | — | US | disclosed |
| US-20120041093-A1 | POLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2012-02-16 | — | — | US | disclosed |
| WO-2010112410-A1 | POLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2010-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041093-A1 | POLYMERIZABLE COMPOSITIONS | H1-10, CBR1, NR1H2 | MAPT 3756/4885ALDH1A1 3185/4885TP53 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.